August 2018 Issue

GO TO FULL ISSUE

MED UPDATES

Steglatro
ertugliflozin
An SGLT2 inhibitor for type 2 diabetes

Symtuza
darunavir/cobicistat/emtricitabine/ tenofovir alafenamide
A new combination regimen for HIV-1 infection

Foquest
methylphenidate
A new controlled-release formulation for ADHD in adults

MORE MED UPDATES